You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 9, September 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cyclosporine Therapy and Refractory Pneumocystis carinii Pneumonia

A Potential Association

Timothy R. Franson, MD; H. Myron Kauffman, Jr, MD; Mark B. Adams, MD; Jacob Lemann, Jr, MD; Edwin Cabrera, MD; Linda Hanacik, RN

Arch Surg. 1987;122(9):1034-1035.


Abstract

• In surveillance of 75 patients receiving renal transplants in 1984 at our Institution, five cases of Pneumocystis carinii pneumonia were detected. All five cases occurred in a subgroup of 11 patients who had received cyclosporine. A retrospective epidemiologic survey of the infected patients revealed all five were heterosexual white men with onset of Pneumocystis pneumonia two to six months after cadaveric transplantation. All received cyclosporine and corticosteroids, and four of five patients also received azathioprine; none was neutropenic or had evidence of concurrent cytomegalovirus infection. Only one of these patients responded to therapy with sulfamethoxazole and trimethoprim, one patient responded to pentamidine therapy, and the remaining three patients died. Cyclosporine use may be related to development of Pneumocystis infections that are refractory to conventional antiprotozoal therapy, and transplantation programs should closely survey patients for such complications.

(Arch Surg 1987;122:1034-1035)



Author Affiliations

From the Departments of Medicine (Drs Franson and Lemann), Surgery (Drs Kauffman, Adams, and Cabrera), and Infection Control (Ms Hanacik), Froedtert Memorial Lutheran Hospital, Medical College of Wisconsin, Milwaukee. Dr Franson is now with Lilly Research Laboratories, Indianapolis.


Footnotes

Accepted for publication Oct 22, 1986.

Reprint requests to Chemotherapy, MC754, 31/3, Lilly Research Laboratories, Lilly Corp Center, Indianapolis, IN 46285 (Dr Franson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Meta-analysis of Salvage Therapy for Pneumocystis carinii Pneumonia
Smego et al.
Arch Intern Med 2001;161:1529-1533.
ABSTRACT | FULL TEXT  

Pneumocystis carinii Pneumonia Without Acquired Immunodeficiency Syndrome: More Patients, Same Risk
Sepkowitz et al.
Arch Intern Med 1995;155:1125-1128.
ABSTRACT  

Pneumocystis carinii Pneumonia Among Patients Without AIDS at a Cancer Hospital
Sepkowitz et al.
JAMA 1992;267:832-837.
ABSTRACT  

Pneumocystis carinii Pneumonia in Renal Transplant Recipients-Reply
FRANSON and ADAMS
Arch Surg 1988;123:913-913.
ABSTRACT  

Pneumocystis carinii Pneumonia in Renal Transplant Recipients
JOHNSON et al.
Arch Surg 1988;123:912-913.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.